Selection of the third cardiovascular target by Servier marks the first milestone for miRagen under the collaboration. Servier chief executive officer Dr. Jean-Philippe Seta said, "Micro-RNA is now
OMS824 is developed to selectively inhibit phosphodiesterase 10 enzyme that is expressed in areas of the brain associated with an array of diseases affecting cognition, such as Huntington’s
The late stage products to be submitted for approval include drugs targeting varying diseases such as hepatitis C, immune diseases and schizophrenia, and vaccines for flu, rabies and
The opening of the new facility, which was independently audited and approved as cGMP compliant, represents the final phase of moving Bellwyck’s clinical services from the Patheon Reading
The marketing authorization received for Vesomni is related to the "treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic
The FDA had approved Diclegis as the only treatment for nausea and vomiting of pregnancy (NVP) when conservative management fails. Duchesnay USA chief executive officer Gilbert Godin said
Details of the transaction have not been revealed, however, it is expected that the 725,000ft² property would be handed over by Merck on 28 June 2013. The consortium
The patent claims describe methods of preparing an immunologically-active adjuvant-bound, thermostable, freeze dried vaccine composition that uses conventional adjuvants comprised of aluminum salts, in addition to claims covering
Focused on advancing the proprietary diagnostic technology, originally developed by Lilly, the collaboration agreement is part of Corgenix’ expanded contract services business unit for the healthcare and biotechnology
The company submitted a biologics license application (BLA) to the FDA for its pegylated subcutaneous injectable candidate developed for relapsing forms of multiple sclerosis. The BLA application included
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.